Newsroom

Sorted by: Latest

-

FORSEE POWER : Informations relatives au nombre de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers (AMF)

PARIS--(BUSINESS WIRE)--Regulatory News: FORSEE POWER (Paris:FORSE): Date Nombre d’actions composant le capital social Nombre de droits de vote BRUT (1) Nombre de droits de vote NET (2) 31/12/2025 117 462 013 125 125 519 124 603 414 (1) Conformément à l’article 223-11 du Règlement général de l’Autorité des marchés financiers, nombre calculé sur la base de l’ensemble des actions auxquelles sont attachées des droits de vote, y compris les actions privées de droit de vote (auto-détention, contrat...
-

MediaCo’s HOT 97 Launches New Morning Show: HOT 97 Mornings with Mero, Premiering Tuesday, January 13, 6AM–10AM

NEW YORK--(BUSINESS WIRE)--MediaCo’s HOT 97 (WQHT-FM), New York’s #1 multicultural station regardless of language, today announced the launch of its brand-new morning show, HOT 97 Mornings with Mero, premiering Tuesday, January 13, airing 6:00 a.m. to 10:00 a.m. ET. The show will be hosted by The Kid Mero, one of New York’s most recognizable and authentic voices in media and culture. Hailing from the Bronx, The Kid Mero is a New York Times best-selling author, Writers Guild Award winner, and a...
-

Liberty All-Star® Growth Fund, Inc. Declares Distribution

BOSTON--(BUSINESS WIRE)--The Board of Directors of Liberty All-Star Growth Fund, Inc. (NYSE: ASG) has declared a distribution of $0.12 per share payable on March 9, 2026 to shareholders of record on January 22, 2026. This distribution is in accordance with the Fund’s current distribution policy of paying distributions on its shares totaling approximately 8 percent of its net asset value per year, payable in four quarterly installments of 2 percent. A portion of the distribution may be treated a...
-

Dan Wheeler Announces Campaign for Congress in California's 11th District

SAN FRANCISCO--(BUSINESS WIRE)--Daniel Wheeler today announced his candidacy for the United States House of Representatives in California's 11th District, pledging to restore San Francisco's position as America's beacon of innovation, progress and common-sense leadership. San Francisco is overdue for representation by someone unbeholden to special interests or responsible for the misuse of public funds. Wheeler is laser focused on San Franciscans’ priorities: Economic Growth and Affordability:...
-

emeis : Programme de rachat de titres

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: Déclaration des transactions sur actions propres Période du 5 au 9 janvier 2026 Emetteur : EMEIS (LEI : 969500LHIH3NT7PK1V89) (Paris:EMEIS) Catégories de titres : actions ordinaires (ISIN : FR001400NLM4) Descriptif du programme mis en ligne sur le site Internet de l’Autorité des Marchés Financiers le 12 janvier 2026 Rapport hebdomadaire sur les rachats d'actions du 5 au 9 janvier 2026   Nom de l'émetteur Code identifiant de l'émetteur (code LEI...
-

insitro to Acquire CombinAbleAI to Complete its Full Stack, Modality-Agnostic AI Platform for Drug Discovery and Design

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, the AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro’s TherML™ (Therapeutic Machine Learning) platform. The acquisition, which is expected to close in late January 2026, will complete insitro's full stack, modality-agnostic capability spanning small molecules, oligonucleotides, antibodies, and other complex biologics with precision – enabling biology to guide both mod...
-

Medincell: Publication of the 2026 Financial Calendar

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Paris:MEDCL): Event Date Annual results 2025-2026 (April 2025-March 2026) Tuesday, June 16, 2026 General Meeting Thursday, September 10, 2026 Half-Year results 2026-2027 (April-September 2026) Tuesday, December 8, 2026 About Medincell Medincell is a clinical- and commercial-stage biopharmaceutical licensing company developing long-acting injectable treatments across multiple therapeutic areas. Our innovative treatments are design...
-

Owkin Brings Biology Super Intelligence Closer to Reality with New AI Infrastructure for Biological Breakthroughs

SAN FRANCISCO--(BUSINESS WIRE)--Owkin, the AI company on a mission to solve the complexity of biology, today announced the launch of its agentic infrastructure for biology, making its best-in-class AI agents available to the healthcare ecosystem. The announcement comes at the JPM Healthcare Conference 2026 and follows Owkin’s recent strategic partnerships and its just-announced integration with Claude for Healthcare and Life Sciences by Anthropic. Owkin, a 10-year-old AI company with $300 milli...
-

Liberty All-Star® Equity Fund Declares Distribution

BOSTON--(BUSINESS WIRE)--The Board of Trustees of Liberty All-Star Equity Fund (NYSE: USA) has declared a distribution of $0.18 per share payable on March 9, 2026 to shareholders of record on January 22, 2026. This distribution is in accordance with the Fund’s current distribution policy of paying distributions on its shares totaling approximately 10 percent of its net asset value per year, payable in four quarterly installments of 2.5 percent. A portion of the distribution may be treated as pa...
-

Curion Expands Global Delivery Capabilities Through Acquisition of Blue Yonder

DEERFIELD, Ill. and LEEDS, England--(BUSINESS WIRE)--Curion, a portfolio company of Summit Park, is pleased to announce the acquisition of Blue Yonder Research, a United Kingdom-based market research agency specializing in research and development (R&D) and innovation insights. The partnership strengthens Curion’s global delivery capabilities for multinational clients, expands its addressable market, and reinforces its position in core end markets where the company has built deep expertise...